[Multiple sclerosis: current therapeutic strategies].
Chofflon
Michel
M
Clinique et Policlinique de Neurologie, Laboratoire de Neuroimmunologie, HUG, Genève. michel.chofflon@hcuge.ch
D000906:Antibodies / Q000627:therapeutic use; D003376:Counseling; D006801:Humans; D007267:Injections; D016898:Interferon-alpha / Q000627:therapeutic use; D016899:Interferon-beta / Q000008:administration & dosage / Q000276:immunology; D009103:Multiple Sclerosis / Q000150:complications / Q000628:therapy*; D012720:Severity of Illness Index
D000906:Antibodies; D016898:Interferon-alpha; D016899:Interferon-beta